In the last trading session, 97.8 million shares of the Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) were traded, and its beta was 0.66. Most recently the company’s share price was $15.10, and it changed around $11.23 or 290.18% from the last close, which brings the market valuation of the company to $9.66M. GLMD currently trades at a discount to its 52-week high of $10.50, offering almost 30.46% off that amount. The share price’s 52-week low was $2.73, which indicates that the current value has risen by an impressive 81.92% since then. We note from Galmed Pharmaceuticals Ltd’s average daily trading volume that its 10-day average is 10.04 million shares, with the 3-month average coming to 75.57K.
Galmed Pharmaceuticals Ltd stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 5 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended GLMD as a Hold, whereas 5 deemed it a Buy, and 0 rated it as Underweight. Galmed Pharmaceuticals Ltd is expected to report earnings per share of 0 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) trade information
Instantly GLMD has showed a green trend with a performance of 290.18% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 23.80 on recent trading dayincreased the stock’s daily price by 36.55%. The company’s shares are currently up 176.56% year-to-date, but still up 324.16% over the last five days. On the other hand, Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) is 349.40% up in the 30-day period. We can see from the shorts that 40640.0 shares have been sold at a short interest cover period of 0.42 day(s).
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 21.08%.
GLMD Dividends
Galmed Pharmaceuticals Ltd’s next quarterly earnings report is expected to be released in October.
